The Anonymized Data of H56 POR Clinical Trial
Baknine, El Mehdi; Hu, Tu;
The Anonymized Data of H56 POR Clinical Trial
This dataset is derived from "A Phase 2, Double-blind, Randomised, Placebo-Controlled Study to Evaluate the Safety and Efficacy of H56:IC31® in Reducing the Rate of TB Disease Recurrence in HIV Negative Adults Successfully Treated for Drug-Susceptible Pulmonary Tuberculosis" (ClinicalTrials.gov number: NCT03512249). The results have been reported in The Lancet Infectious Diseases (https://doi.org/10.1016/S1473-3099(24)00814-4) To request access to the data, please contact Tu Hu at tuhu@ssi.dk.
- Statens Serum Institut Denmark
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).0 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
selected citations
Citations provided by BIP!
These citations are derived from selected sources.
This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
Citations provided by BIP!popularityPopularity provided by BIP!
This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
Popularity provided by BIP! 0
Average
Average
Average